Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington’s disease

被引:0
作者
Ya Zhou
Thomas R. Peskett
Christian Landles
John B. Warner
Kirupa Sathasivam
Edward J. Smith
Shu Chen
Ronald Wetzel
Hilal A. Lashuel
Gillian P. Bates
Helen R. Saibil
机构
[1] University College London,Huntington’s Disease Centre, Department of Neurodegenerative Disease and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology
[2] Birkbeck College,Institute of Structural and Molecular Biology
[3] ETH Zurich,Department of Biology, Institute of Biochemistry
[4] École Polytechnique Fédérale de Lausanne (EPFL),Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute
[5] University of Pittsburgh School of Medicine,Department of Structural Biology
来源
Acta Neuropathologica Communications | / 9卷
关键词
Huntington’s disease; Correlative light and electron microscopy; Electron tomography; Huntingtin aggregation; Polyglutamine; Endolysosomal system; Multivesicular body; Amphisome; Autolysosome; Exocytosis;
D O I
暂无
中图分类号
学科分类号
摘要
Huntington’s disease (HD) is a late onset, inherited neurodegenerative disorder for which early pathogenic events remain poorly understood. Here we show that mutant exon 1 HTT proteins are recruited to a subset of cytoplasmic aggregates in the cell bodies of neurons in brain sections from presymptomatic HD, but not wild-type, mice. This occurred in a disease stage and polyglutamine-length dependent manner. We successfully adapted a high-resolution correlative light and electron microscopy methodology, originally developed for mammalian and yeast cells, to allow us to correlate light microscopy and electron microscopy images on the same brain section within an accuracy of 100 nm. Using this approach, we identified these recruitment sites as single membrane bound, vesicle-rich endolysosomal organelles, specifically as (1) multivesicular bodies (MVBs), or amphisomes and (2) autolysosomes or residual bodies. The organelles were often found in close-proximity to phagophore-like structures. Immunogold labeling localized mutant HTT to non-fibrillar, electron lucent structures within the lumen of these organelles. In presymptomatic HD, the recruitment organelles were predominantly MVBs/amphisomes, whereas in late-stage HD, there were more autolysosomes or residual bodies. Electron tomograms indicated the fusion of small vesicles with the vacuole within the lumen, suggesting that MVBs develop into residual bodies. We found that markers of MVB-related exocytosis were depleted in presymptomatic mice and throughout the disease course. This suggests that endolysosomal homeostasis has moved away from exocytosis toward lysosome fusion and degradation, in response to the need to clear the chronically aggregating mutant HTT protein, and that this occurs at an early stage in HD pathogenesis.
引用
收藏
相关论文
共 50 条
[11]   Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease [J].
Yu, ZX ;
Li, SH ;
Evans, J ;
Pillarisetti, A ;
Li, H ;
Li, XJ .
JOURNAL OF NEUROSCIENCE, 2003, 23 (06) :2193-2202
[12]   Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients [J].
Pierzynowska, Karolina ;
Gaffke, Lidia ;
Cyske, Zuzanna ;
Wegrzyn, Grzegorz .
METABOLIC BRAIN DISEASE, 2019, 34 (03) :715-720
[13]   Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis [J].
Lee, C. Y. Daniel ;
Cantle, Jeffrey P. ;
Yang, X. William .
FEBS JOURNAL, 2013, 280 (18) :4382-4394
[14]   Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression [J].
Bahat, Anat ;
Itzhaki, Elad ;
Weiss, Benjamin ;
Tolmasov, Michael ;
Tsoory, Michael ;
Kuperman, Yael ;
Brandis, Alexander ;
Shurrush, Khriesto A. ;
Dikstein, Rivka .
EMBO MOLECULAR MEDICINE, 2024, 16 (03) :523-546
[15]   Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene [J].
Franich, Nicholas R. ;
Hickey, Miriam A. ;
Zhu, Chunni ;
Osborne, Georgina F. ;
Ali, Nadira ;
Chu, Tiffany ;
Bove, Nicholas H. ;
Lemesre, Vincent ;
Lerner, Renata P. ;
Zeitlin, Scott O. ;
Howland, David ;
Neueder, Andreas ;
Landles, Christian ;
Bates, Gillian P. ;
Chesselet, Marie-Francoise .
JOURNAL OF NEUROSCIENCE RESEARCH, 2019, 97 (12) :1590-1605
[16]   Mutant Huntingtin Affects Diabetes and Alzheimer's Markers in Human and Cell Models of Huntington's Disease [J].
Chaves, Gepoliano ;
Stanley, John ;
Pourmand, Nader .
CELLS, 2019, 8 (09)
[17]   Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease [J].
Valionyte, Evelina ;
Yang, Yi ;
Roberts, Sheridan L. ;
Kelly, Jack ;
Lu, Boxun ;
Luo, Shouqing .
JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (08) :2673-2691
[18]   Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease [J].
Bergh, Sofia ;
Gabery, Sanaz ;
Tonetto, Simone ;
Kirik, Deniz ;
Petersen, Asa ;
Cheong, Rachel Y. .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (02)
[19]   PRMT5-mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD) [J].
Ratovitski, Tamara ;
Arbez, Nicolas ;
Stewart, Jacqueline C. ;
Chighladze, Ekaterine ;
Ross, Christopher A. .
CELL CYCLE, 2015, 14 (11) :1716-1729
[20]   Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington's Disease [J].
Chaudhary, Rajeev Kumar ;
Kardani, Jay ;
Singh, Kuljit ;
Banerjee, Ruchira ;
Roy, Ipsita .
NEUROMOLECULAR MEDICINE, 2014, 16 (02) :280-291